| Followers | 200 |
| Posts | 25597 |
| Boards Moderated | 0 |
| Alias Born | 04/03/2010 |
Sunday, October 16, 2022 3:38:39 AM
There is a difference here. There was no ”release” and the company has said nothing about meeting endpoints. What you heard was the presentations of third-party scientists who ran the trial. No one has seen the slides or the video of those presentations anywhere else but on a third-party charitable website and on the original forum website, and yet a critic like Adam Fuerstein wants to imply The Company committed fraud or did x,y or x. The facts are different than these critics want to say, but boy do they scream and repeat the false narratives, over and over. They’re so frustrated because it makes them liars.
But the company has announced nothing. Only scientists…who don’t work for the company. Their value is they are independent. They work for research universities, and their value to them and the world, their most valuable commodity is their reputations.
Endpoints were discussed and some data, in those presentation, but not a publication with more than just those highlights. A publication will provide fuller data and analysis.
We know NWBO is still observing an embargo on release of such information. The company never released the endpoints or any discussion thereof in a press release nor have they ever given a press interview.
The answer, therefore is quite obvious, even if some critics want to insist otherwise. People have their agendas, but facts are facts.
But the company has announced nothing. Only scientists…who don’t work for the company. Their value is they are independent. They work for research universities, and their value to them and the world, their most valuable commodity is their reputations.
Endpoints were discussed and some data, in those presentation, but not a publication with more than just those highlights. A publication will provide fuller data and analysis.
We know NWBO is still observing an embargo on release of such information. The company never released the endpoints or any discussion thereof in a press release nor have they ever given a press interview.
The answer, therefore is quite obvious, even if some critics want to insist otherwise. People have their agendas, but facts are facts.
I own NWBO. My posts on iHub are always posted expressly as just my humble opinion (IMHO) and none are advice, just my opinion. I am NOT a financial advisor, and it is assumed that everyone is responsible for their own due diligence.
Recent NWBO News
- Northwest Biotherapeutics Announces Establishment Of the Company's Own Dedicated Leukapheresis Clinic • PR Newswire (US) • 04/21/2026 01:30:00 PM
- Northwest Biotherapeutics Announces Establishment Of the Company's Own Dedicated Leukapheresis Clinic • PR Newswire (US) • 04/21/2026 01:30:00 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 04/21/2026 04:15:08 AM
- Form POS AM - Post-Effective amendments for registration statement • Edgar (US Regulatory) • 04/16/2026 09:25:30 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/07/2026 04:30:50 PM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 03/31/2026 09:04:37 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/15/2026 10:06:20 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/02/2026 10:14:59 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 11/28/2025 09:43:27 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 11/25/2025 10:23:07 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/20/2025 09:26:03 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 11/19/2025 09:15:48 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/14/2025 09:44:21 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/31/2025 04:29:10 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/30/2025 08:40:05 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/24/2025 04:28:38 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/14/2025 06:22:26 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2025 09:00:38 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 07/01/2025 09:04:38 PM
